3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Telemedicine stocks could do no wrong during the pandemic. With millions on lockdown and still in need of medical care, telemedicine stocks, like Teledoc Health (NYSE:TDOC) ranfrom about $80 to a high of $288.80.
Teladoc: Falling Knife Status Or Kitchen Sink Guidance?
Teladoc's new management has delivered a painful FQ2'24 earnings call, as observed in the BetterHelp impairment costs and withdrawn forward guidance. It is apparent that the telehealth company is facing growth issues and elevated marketing/advertising costs, with its near-term prospects likely to remain underwhelming. Readers must note the upcoming Livongo notes are likely to trigger further equity dilution, worsening the highly shorted stock's ongoing insider selling.
Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat
Teladoc Health (TDOC) expects revenue growth in the Integrated Care segment to be within low to mid-single-digit growth in 2024, on a year-over-year basis.
Teladoc Post Q2 Earnings: Stick A Fork In This Stock - It's Nearly Done (For)
Teladoc Health, Inc. stock has plummeted >95% since its peak in early 2021, with the downtrend near constant. Losses are usually exacerbated by quarterly earnings, and Q2 earnings, announced yesterday, were no exception. Teladoc's new CEO withdrew all guidance for 2024, signaling potential challenges ahead, especially with the BetterHelp segment facing high customer acquisition costs and churn.
Teladoc shares hit record low after telehealth firm withdraws 2024 forecast
Teladoc Health's shares hit a record low on Thursday, as surging costs and declining revenue in its mental health services unit forced the virtual healthcare provider to withdraw its annual and long-term forecasts.
Why Teladoc Stock Got Socked for a Loss Thursday
Teladoc reported a massive charge to earnings last night, and a huge earnings miss. The telemedicine company is still working through the consequences of its $18.5 billion purchase of Livongo four years ago.
Teladoc Health, Inc. (TDOC) Q2 2024 Earnings Call Transcript
Teladoc Health, Inc. (NYSE:TDOC ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Michael Minchak - Head of Investor Relations Conference Call Participants Lisa Gill - J.P. Morgan Stephanie Davis - Barclays Jess Tassan - Piper Sandler Jailendra Singh - Truist Securities Richard Close - Cannacord Genuity Elizabeth Anderson - Evercore ISI Sarah James - Cantor Fitzgerald Sean Dodge - RBC Capital Markets Charles Rhyee - TD Cowen Michael Cherny - Leerink Partners Daniel Grosslight - Citi Operator Hello all, and welcome to Teladoc Health Second Quarter 2024 Earnings Call.
Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Teladoc (TDOC) Reports Q2 Loss, Misses Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.40 per share a year ago.
Teladoc posts another quarterly loss, and online mental-health unit sees revenue slip
Shares of Teladoc Health Inc. fell more than 15% in the extended session Wednesday after the once high-flying telehealth company posted a much larger-than-expected quarterly loss and withdrew its guidance for the year.
Teladoc Stock Falls Below 52-Week Lows On Q2 Earnings: Guidance Withdrawn On BetterHealth Weakness, 'Focused On Addressing The Work Ahead Of Us With Urgency'
Telehealth company Teladoc Health Inc TDOC reported second-quarter financial results after market close Wednesday.
Can Teladoc (TDOC) Q2 Earnings Navigate BetterHelp Profit Woes?
Teladoc's (TDOC) second-quarter results are likely to reflect lower advertising and marketing expenses.
